Next Article in Journal
Evidence That a Peptide-Drug/p53 Gene Complex Promotes Cognate Gene Expression and Inhibits the Viability of Glioblastoma Cells
Next Article in Special Issue
Toward Personalized Salbutamol Therapy: Validating Virtual Patient-Derived Population Pharmacokinetic Model with Real-World Data
Previous Article in Journal
Dual Effect by Chemical Electron Transfer Enhanced siRNA Lipid Nanoparticles: Reactive Oxygen Species-Triggered Tumor Cell Killing Aggravated by Nrf2 Gene Silencing
Previous Article in Special Issue
Safety Evaluation and Population Pharmacokinetics of Camostat Mesylate and Its Major Metabolites Using a Phase I Study
 
 
Article

Article Versions Notes

Pharmaceutics 2024, 16(6), 780; https://doi.org/10.3390/pharmaceutics16060780
Action Date Notes Link
article pdf uploaded. 8 June 2024 08:56 CEST Version of Record https://www.mdpi.com/1999-4923/16/6/780/pdf-vor
article pdf uploaded. 8 June 2024 09:20 CEST Updated version of record https://www.mdpi.com/1999-4923/16/6/780/pdf-vor
article pdf uploaded. 8 June 2024 09:39 CEST Updated version of record https://www.mdpi.com/1999-4923/16/6/780/pdf-vor
article xml file uploaded 26 June 2024 10:10 CEST Original file -
article xml uploaded. 26 June 2024 10:10 CEST Update https://www.mdpi.com/1999-4923/16/6/780/xml
article pdf uploaded. 26 June 2024 10:11 CEST Updated version of record https://www.mdpi.com/1999-4923/16/6/780/pdf
article html file updated 26 June 2024 10:13 CEST Original file https://www.mdpi.com/1999-4923/16/6/780/html
Back to TopTop